Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells
ConclusionsOur current results suggest that the application of HDACi in combination with drugs that target DNMT may represent a promising option for the treatment of medulloblastoma.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer Therapy | Medulloblastoma | Neurology | Stem Cell Therapy | Stem Cells | Study